(PDF) Oral Administration of a Specific Kynurenic Acid

Oral Administration of a Specific Kynurenic Acid Synthesis (KAT II) Inhibitor Attenuates Evoked Glutamate Release in Rat Prefrontal Cortex

Neuropharmacology - United Kingdom

doi 10.1016/j.neuropharm.2017.04.023

Full Text

Abstract

Available in full text

Categories

Molecular Neuroscience

Date

July 1, 2017

Authors

Publisher

Elsevier BV

Related search

Inhibition of Evoked Glutamate Release by Neurosteroid Allopregnanolone via Inhibition of L-Type Calcium Channels in Rat Medial Prefrontal Cortex

Neuropsychopharmacology

English

The Astrocyte-Derived Α7 Nicotinic Receptor Antagonist Kynurenic Acid Controls Extracellular Glutamate Levels in the Prefrontal Cortex

Journal of Molecular Neuroscience

Molecular Neuroscience

English

Repeated Cocaine Administration Impairs Group II Metabotropic Glutamate Receptor-Mediated Long-Term Depression in Rat Medial Prefrontal Cortex

Journal of Neuroscience

English

Avenaciolide: A Specific Inhibitor of Glutamate Transport in Rat Liver Mitochondria

Biochemical Journal

English

Potassium-Evoked Glutamate Release Liberates Arachidonic Acid From Cortical Neurons

Journal of Biological Chemistry

Molecular Biology

English

Tautomeric Polymorphism of the Neuroactive Inhibitor Kynurenic Acid

English

Curcumin Inhibits Glutamate Release From Rat Prefrontal Nerve Endings by Affecting Vesicle Mobilization

International Journal of Molecular Sciences

Organic Chemistry

Molecular Biology

Theoretical Chemistry

Inorganic Chemistry

Computer Science Applications

English

Single Prolonged Stress Decreases Glutamate, Glutamine, and Creatine Concentrations in the Rat Medial Prefrontal Cortex

Neuroscience Letters

English

Interaction of Dopamine D1 and NMDA Receptors Mediates Acute Clozapine Potentiation of Glutamate EPSPs in Rat Prefrontal Cortex

Journal of Neurophysiology

English